Literature DB >> 15336334

No evidence for sex differences in the severity and treatment of cancer pain.

Janet M Edrington1, Steven Paul, Marylin Dodd, Claudia West, Noreen Facione, Debu Tripathy, Peter Koo, Karen Schumacher, Christine Miaskowski.   

Abstract

While chronic pain is experienced by approximately 50-90% of patients with metastatic cancer, little is known about sex differences in chronic cancer pain. Therefore, the purposes of this study, in a sample of oncology outpatients (n=187) who were experiencing pain from bone metastasis, were: 1) to determine if there were sex differences in various pain characteristics, including pain intensity, and 2) to determine if there were sex differences in the prescription and consumption of analgesic medications. No significant sex differences were found in any of the baseline pain characteristics. In addition, no significant sex differences were found in analgesic prescriptions or intake of analgesic medications. Of note, men reported significantly higher pain interference scores for sexual activity than women. The study findings are important because they suggest that, unlike in acute pain, sex may not influence patients' perceptions of and responses to chronic cancer pain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15336334     DOI: 10.1016/j.jpainsymman.2003.12.013

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  16 in total

1.  Gender and ethnic differences in cancer pain experience: a multiethnic survey in the United States.

Authors:  Eun-Ok Im; Wonshik Chee; Enrique Guevara; Yi Liu; Hyun-Ju Lim; Hsiu-Min Tsai; Maresha Clark; Melinda Bender; Kyung Suk Kim; Young Hee Kim; Hyunjeong Shin
Journal:  Nurs Res       Date:  2007 Sep-Oct       Impact factor: 2.381

2.  Cancer patients' first treatment episode with opioids: a pharmaco-epidemiological perspective.

Authors:  Lene Jarlbaek; Jesper Hallas; Jakob Kragstrup; Morten Andersen
Journal:  Support Care Cancer       Date:  2005-09-27       Impact factor: 3.603

3.  A comparison of change in the 0-10 numeric rating scale to a pain relief scale and global medication performance scale in a short-term clinical trial of breakthrough pain intensity.

Authors:  John T Farrar; Rosemary C Polomano; Jesse A Berlin; Brian L Strom
Journal:  Anesthesiology       Date:  2010-06       Impact factor: 7.892

4.  White cancer patients' perception of gender and ethnic differences in pain experience.

Authors:  Eun-Ok Im
Journal:  Cancer Nurs       Date:  2006 Nov-Dec       Impact factor: 2.592

5.  A national online forum on ethnic differences in cancer pain experience.

Authors:  Eun-Ok Im; Seung Hee Lee; Yi Liu; Hyun-Ju Lim; Enrique Guevara; Wonshik Chee
Journal:  Nurs Res       Date:  2009 Mar-Apr       Impact factor: 2.381

Review 6.  Sex differences and hormonal modulation of deep tissue pain.

Authors:  Richard J Traub; Yaping Ji
Journal:  Front Neuroendocrinol       Date:  2013-07-17       Impact factor: 8.606

7.  An online forum exploring needs for help of patients with cancer: gender and ethnic differences.

Authors:  Eun-Ok Im; Wonshik Chee; Hyun-Ju Lim; Wen-Miao Liu
Journal:  Oncol Nurs Forum       Date:  2008-07       Impact factor: 2.172

8.  Predictors of patterns of pain, fatigue, and insomnia during the first year after a cancer diagnosis in the elderly.

Authors:  Sharon L Kozachik; Karen Bandeen-Roche
Journal:  Cancer Nurs       Date:  2008 Sep-Oct       Impact factor: 2.592

9.  Factors associated with pain among ambulatory patients with cancer with advanced disease at a comprehensive cancer center.

Authors:  Sherri O Stuver; Thomas Isaac; Jane C Weeks; Susan Block; Donna L Berry; Roger B Davis; Saul N Weingart
Journal:  J Oncol Pract       Date:  2012-03-06       Impact factor: 3.840

Review 10.  Sex, gender, and pain: a review of recent clinical and experimental findings.

Authors:  Roger B Fillingim; Christopher D King; Margarete C Ribeiro-Dasilva; Bridgett Rahim-Williams; Joseph L Riley
Journal:  J Pain       Date:  2009-05       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.